Does Kawasaki disease cause a rash on the face?

Written by Li Jiao Yan

Neonatology

Updated on September 05, 2024

00:00

00:00

The pathogenesis of Kawasaki disease is unclear, and the main pathological change is systemic vasculitis. Typically, the rash is a polymorphic erythema or a scarlatiniform rash, primarily occurring on the trunk. Generally, facial rashes are rare, but it's not entirely impossible for rashes to appear on the face. Therefore, if a baby develops a rash on the face without other infections, Kawasaki disease might also present this symptom.

Other Voices

home-news-image

Written by Yan Xin Liang

Pediatrics

59sec

home-news-image

Kawasaki disease sequelae

Kawasaki disease is an autoimmune vasculitis, and since it is vasculitis, it can originate from blood vessels in various parts, including the heart, liver, kidneys, brain, and more. However, it mainly arises from the coronary arteries of the heart. If Kawasaki disease is not effectively treated, some patients can develop coronary artery dilation and even coronary artery aneurysms. Once a coronary artery aneurysm occurs, its complication includes the risk of rupture and bleeding of the aneurysm, which can be difficult to treat if there is severe bleeding. If there is some coronary artery dilation, it can lead to the formation of coronary artery thrombosis, which is also a complication it can cause. However, the vast majority of Kawasaki disease cases, if treated effectively, can prevent coronary artery abnormalities. Therefore, as long as the treatment is timely, most cases will not have significant lasting effects.

home-news-image

Written by Li Jiao Yan

Neonatology

1min 26sec

home-news-image

How long does it take to cure Kawasaki disease?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, has unclear etiology and pathogenesis. The primary pathological change is systemic vasculitis, frequently affecting the coronary arteries. Kawasaki disease is considered a self-limiting condition, with most cases having a good prognosis; recurrence occurs in 1% to 2% of affected children. If associated with coronary artery damage and not effectively treated, 15% to 25% of these cases can develop coronary artery aneurysms. Typically, coronary artery aneurysms resolve within two years of onset, but often leave residual arterial wall thickening and reduced elasticity. Large aneurysms do not disappear completely and can lead to thrombosis or stenosis. Kawasaki disease is also one of the main causes of acquired heart disease in children. Therefore, active and effective treatment of Kawasaki disease can result in recovery. However, if there is accompanying coronary artery damage, the prognosis can vary depending on the extent of the damage. Severe coronary artery damage might lead to long-term heart disease.

home-news-image

Written by Li Jiao Yan

Neonatology

42sec

home-news-image

Is Kawasaki disease contagious?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, currently has unclear pathogenic mechanisms and the causes of the disease are not well defined. One of its main pathological changes is systemic vasculitis, including the coronary arteries. The disease occurs sporadically or in small epidemics, can happen in any season without clear seasonality, and is generally more common in infants and young children, with eighty percent under five years of age. Kawasaki disease is not a contagious disease, so it does not have significant contagiousness.

home-news-image

Written by Yao Li Qin

Pediatrics

1min 16sec

home-news-image

How is Kawasaki disease treated?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, can cause damage to the coronary arteries in untreated children, so it is crucial to treat the disease promptly once diagnosed. This disease generally occurs sporadically or in small outbreaks and can occur in any season, predominantly affecting infants and young children. The main treatment for Kawasaki disease is aspirin, which not only reduces fever but also helps reduce coronary artery lesions. Additionally, intravenous immunoglobulin is administered; however, the use of corticosteroids in Kawasaki disease is still somewhat controversial. Other treatments mainly include antiplatelet aggregation agents such as dipyridamole, and symptomatic supportive care for the child, including fluid supplementation, heart protection, control of heart failure, and correction of arrhythmias. For severe coronary artery lesions, coronary artery bypass surgery may be required. (Please use medication under the guidance of a professional physician.)

home-news-image

Written by Li Jiao Yan

Neonatology

32sec

home-news-image

Does Kawasaki disease cause a rash on the face?

The pathogenesis of Kawasaki disease is unclear, and the main pathological change is systemic vasculitis. Typically, the rash is a polymorphic erythema or a scarlatiniform rash, primarily occurring on the trunk. Generally, facial rashes are rare, but it's not entirely impossible for rashes to appear on the face. Therefore, if a baby develops a rash on the face without other infections, Kawasaki disease might also present this symptom.